Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
25,125
archived clinical trials in
Diabetes

Post Approval Study of the TS Feature With the 530G Pump System Supplemented With Commercial Patient Data
Post Approval Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System Supplemented With Commercial Patient Data
Status: Enrolling
Updated:  12/31/1969
The Diabetes Center
736
mi
from 43215
Ocean Springs, MS
Post Approval Study of the TS Feature With the 530G Pump System Supplemented With Commercial Patient Data
Post Approval Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System Supplemented With Commercial Patient Data
Status: Enrolling
Updated: 12/31/1969
The Diabetes Center
736
mi
from 43215
Ocean Springs, MS
Click here to add this to my saved trials
Post Approval Study of the TS Feature With the 530G Pump System Supplemented With Commercial Patient Data
Post Approval Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System Supplemented With Commercial Patient Data
Status: Enrolling
Updated:  12/31/1969
Children's Mercy Hospital
618
mi
from 43215
Kansas City, MO
Post Approval Study of the TS Feature With the 530G Pump System Supplemented With Commercial Patient Data
Post Approval Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System Supplemented With Commercial Patient Data
Status: Enrolling
Updated: 12/31/1969
Children's Mercy Hospital
618
mi
from 43215
Kansas City, MO
Click here to add this to my saved trials
Post Approval Study of the TS Feature With the 530G Pump System Supplemented With Commercial Patient Data
Post Approval Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System Supplemented With Commercial Patient Data
Status: Enrolling
Updated:  12/31/1969
Glacier View Research Institute-Endocrinology
1640
mi
from 43215
Kalispell, MT
Post Approval Study of the TS Feature With the 530G Pump System Supplemented With Commercial Patient Data
Post Approval Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System Supplemented With Commercial Patient Data
Status: Enrolling
Updated: 12/31/1969
Glacier View Research Institute-Endocrinology
1640
mi
from 43215
Kalispell, MT
Click here to add this to my saved trials
Post Approval Study of the TS Feature With the 530G Pump System Supplemented With Commercial Patient Data
Post Approval Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System Supplemented With Commercial Patient Data
Status: Enrolling
Updated:  12/31/1969
Complete Endocrinology
718
mi
from 43215
Lincoln, NE
Post Approval Study of the TS Feature With the 530G Pump System Supplemented With Commercial Patient Data
Post Approval Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System Supplemented With Commercial Patient Data
Status: Enrolling
Updated: 12/31/1969
Complete Endocrinology
718
mi
from 43215
Lincoln, NE
Click here to add this to my saved trials
Post Approval Study of the TS Feature With the 530G Pump System Supplemented With Commercial Patient Data
Post Approval Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System Supplemented With Commercial Patient Data
Status: Enrolling
Updated:  12/31/1969
Diabetes, Endocrinology, Metabolism Specialties
478
mi
from 43215
Teaneck, NJ
Post Approval Study of the TS Feature With the 530G Pump System Supplemented With Commercial Patient Data
Post Approval Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System Supplemented With Commercial Patient Data
Status: Enrolling
Updated: 12/31/1969
Diabetes, Endocrinology, Metabolism Specialties
478
mi
from 43215
Teaneck, NJ
Click here to add this to my saved trials
Post Approval Study of the TS Feature With the 530G Pump System Supplemented With Commercial Patient Data
Post Approval Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System Supplemented With Commercial Patient Data
Status: Enrolling
Updated:  12/31/1969
Winthrop University Hospital
496
mi
from 43215
Mineola, NY
Post Approval Study of the TS Feature With the 530G Pump System Supplemented With Commercial Patient Data
Post Approval Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System Supplemented With Commercial Patient Data
Status: Enrolling
Updated: 12/31/1969
Winthrop University Hospital
496
mi
from 43215
Mineola, NY
Click here to add this to my saved trials
Post Approval Study of the TS Feature With the 530G Pump System Supplemented With Commercial Patient Data
Post Approval Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System Supplemented With Commercial Patient Data
Status: Enrolling
Updated:  12/31/1969
Rochester General Hospital
357
mi
from 43215
Rochester, NY
Post Approval Study of the TS Feature With the 530G Pump System Supplemented With Commercial Patient Data
Post Approval Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System Supplemented With Commercial Patient Data
Status: Enrolling
Updated: 12/31/1969
Rochester General Hospital
357
mi
from 43215
Rochester, NY
Click here to add this to my saved trials
Post Approval Study of the TS Feature With the 530G Pump System Supplemented With Commercial Patient Data
Post Approval Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System Supplemented With Commercial Patient Data
Status: Enrolling
Updated:  12/31/1969
Joslin Diabetes Center
414
mi
from 43215
Syracuse, NY
Post Approval Study of the TS Feature With the 530G Pump System Supplemented With Commercial Patient Data
Post Approval Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System Supplemented With Commercial Patient Data
Status: Enrolling
Updated: 12/31/1969
Joslin Diabetes Center
414
mi
from 43215
Syracuse, NY
Click here to add this to my saved trials
Post Approval Study of the TS Feature With the 530G Pump System Supplemented With Commercial Patient Data
Post Approval Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System Supplemented With Commercial Patient Data
Status: Enrolling
Updated:  12/31/1969
University at Buffalo, The State University of New York
303
mi
from 43215
Williamsville, NY
Post Approval Study of the TS Feature With the 530G Pump System Supplemented With Commercial Patient Data
Post Approval Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System Supplemented With Commercial Patient Data
Status: Enrolling
Updated: 12/31/1969
University at Buffalo, The State University of New York
303
mi
from 43215
Williamsville, NY
Click here to add this to my saved trials
Post Approval Study of the TS Feature With the 530G Pump System Supplemented With Commercial Patient Data
Post Approval Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System Supplemented With Commercial Patient Data
Status: Enrolling
Updated:  12/31/1969
Physician's East
429
mi
from 43215
Greenville, NC
Post Approval Study of the TS Feature With the 530G Pump System Supplemented With Commercial Patient Data
Post Approval Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System Supplemented With Commercial Patient Data
Status: Enrolling
Updated: 12/31/1969
Physician's East
429
mi
from 43215
Greenville, NC
Click here to add this to my saved trials
Post Approval Study of the TS Feature With the 530G Pump System Supplemented With Commercial Patient Data
Post Approval Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System Supplemented With Commercial Patient Data
Status: Enrolling
Updated:  12/31/1969
Oregon Health and Science University
2026
mi
from 43215
Portland, OR
Post Approval Study of the TS Feature With the 530G Pump System Supplemented With Commercial Patient Data
Post Approval Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System Supplemented With Commercial Patient Data
Status: Enrolling
Updated: 12/31/1969
Oregon Health and Science University
2026
mi
from 43215
Portland, OR
Click here to add this to my saved trials
Post Approval Study of the TS Feature With the 530G Pump System Supplemented With Commercial Patient Data
Post Approval Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System Supplemented With Commercial Patient Data
Status: Enrolling
Updated:  12/31/1969
AM Diabetes & Endocrinology Center
495
mi
from 43215
Bartlett, TN
Post Approval Study of the TS Feature With the 530G Pump System Supplemented With Commercial Patient Data
Post Approval Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System Supplemented With Commercial Patient Data
Status: Enrolling
Updated: 12/31/1969
AM Diabetes & Endocrinology Center
495
mi
from 43215
Bartlett, TN
Click here to add this to my saved trials
Post Approval Study of the TS Feature With the 530G Pump System Supplemented With Commercial Patient Data
Post Approval Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System Supplemented With Commercial Patient Data
Status: Enrolling
Updated:  12/31/1969
Consano Clinical Research, LLC
1126
mi
from 43215
San Antonio, TX
Post Approval Study of the TS Feature With the 530G Pump System Supplemented With Commercial Patient Data
Post Approval Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System Supplemented With Commercial Patient Data
Status: Enrolling
Updated: 12/31/1969
Consano Clinical Research, LLC
1126
mi
from 43215
San Antonio, TX
Click here to add this to my saved trials
Post Approval Study of the TS Feature With the 530G Pump System Supplemented With Commercial Patient Data
Post Approval Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System Supplemented With Commercial Patient Data
Status: Enrolling
Updated:  12/31/1969
Northeast Clinical Research of San Antonio, LLC
1121
mi
from 43215
Schertz, TX
Post Approval Study of the TS Feature With the 530G Pump System Supplemented With Commercial Patient Data
Post Approval Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System Supplemented With Commercial Patient Data
Status: Enrolling
Updated: 12/31/1969
Northeast Clinical Research of San Antonio, LLC
1121
mi
from 43215
Schertz, TX
Click here to add this to my saved trials
Post Approval Study of the TS Feature With the 530G Pump System Supplemented With Commercial Patient Data
Post Approval Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System Supplemented With Commercial Patient Data
Status: Enrolling
Updated:  12/31/1969
Southwestern Vermont Health Care
547
mi
from 43215
Bennington, VT
Post Approval Study of the TS Feature With the 530G Pump System Supplemented With Commercial Patient Data
Post Approval Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System Supplemented With Commercial Patient Data
Status: Enrolling
Updated: 12/31/1969
Southwestern Vermont Health Care
547
mi
from 43215
Bennington, VT
Click here to add this to my saved trials
Post Approval Study of the TS Feature With the 530G Pump System Supplemented With Commercial Patient Data
Post Approval Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System Supplemented With Commercial Patient Data
Status: Enrolling
Updated:  12/31/1969
Tri-Cities Diabetes and Endocrinology Center
1862
mi
from 43215
Richland, WA
Post Approval Study of the TS Feature With the 530G Pump System Supplemented With Commercial Patient Data
Post Approval Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System Supplemented With Commercial Patient Data
Status: Enrolling
Updated: 12/31/1969
Tri-Cities Diabetes and Endocrinology Center
1862
mi
from 43215
Richland, WA
Click here to add this to my saved trials
Post Approval Study of the TS Feature With the 530G Pump System Supplemented With Commercial Patient Data
Post Approval Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System Supplemented With Commercial Patient Data
Status: Enrolling
Updated:  12/31/1969
Billings Clinic
1343
mi
from 43215
Billings, MT
Post Approval Study of the TS Feature With the 530G Pump System Supplemented With Commercial Patient Data
Post Approval Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System Supplemented With Commercial Patient Data
Status: Enrolling
Updated: 12/31/1969
Billings Clinic
1343
mi
from 43215
Billings, MT
Click here to add this to my saved trials
Post Approval Study of the TS Feature With the 530G Pump System Supplemented With Commercial Patient Data
Post Approval Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System Supplemented With Commercial Patient Data
Status: Enrolling
Updated:  12/31/1969
East Coast Institute for Research
682
mi
from 43215
Jacksonville, FL
Post Approval Study of the TS Feature With the 530G Pump System Supplemented With Commercial Patient Data
Post Approval Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System Supplemented With Commercial Patient Data
Status: Enrolling
Updated: 12/31/1969
East Coast Institute for Research
682
mi
from 43215
Jacksonville, FL
Click here to add this to my saved trials
Post Approval Study of the TS Feature With the 530G Pump System Supplemented With Commercial Patient Data
Post Approval Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System Supplemented With Commercial Patient Data
Status: Enrolling
Updated:  12/31/1969
University of Michigan Diabetes Research Center
164
mi
from 43215
Ann Arbor, MI
Post Approval Study of the TS Feature With the 530G Pump System Supplemented With Commercial Patient Data
Post Approval Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System Supplemented With Commercial Patient Data
Status: Enrolling
Updated: 12/31/1969
University of Michigan Diabetes Research Center
164
mi
from 43215
Ann Arbor, MI
Click here to add this to my saved trials
Post Approval Study of the TS Feature With the 530G Pump System Supplemented With Commercial Patient Data
Post Approval Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System Supplemented With Commercial Patient Data
Status: Enrolling
Updated:  12/31/1969
Endeavor Clinical Trials, PA
1137
mi
from 43215
San Antonio, TX
Post Approval Study of the TS Feature With the 530G Pump System Supplemented With Commercial Patient Data
Post Approval Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System Supplemented With Commercial Patient Data
Status: Enrolling
Updated: 12/31/1969
Endeavor Clinical Trials, PA
1137
mi
from 43215
San Antonio, TX
Click here to add this to my saved trials
Post Approval Study of the TS Feature With the 530G Pump System Supplemented With Commercial Patient Data
Post Approval Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System Supplemented With Commercial Patient Data
Status: Enrolling
Updated:  12/31/1969
Barbara Davis Center (1)
1154
mi
from 43215
Aurora, CO
Post Approval Study of the TS Feature With the 530G Pump System Supplemented With Commercial Patient Data
Post Approval Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System Supplemented With Commercial Patient Data
Status: Enrolling
Updated: 12/31/1969
Barbara Davis Center (1)
1154
mi
from 43215
Aurora, CO
Click here to add this to my saved trials
Post Approval Study of the TS Feature With the 530G Pump System Supplemented With Commercial Patient Data
Post Approval Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System Supplemented With Commercial Patient Data
Status: Enrolling
Updated:  12/31/1969
Barbara Davis Center (2)
1154
mi
from 43215
Aurora, CO
Post Approval Study of the TS Feature With the 530G Pump System Supplemented With Commercial Patient Data
Post Approval Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System Supplemented With Commercial Patient Data
Status: Enrolling
Updated: 12/31/1969
Barbara Davis Center (2)
1154
mi
from 43215
Aurora, CO
Click here to add this to my saved trials
Linagliptin Inpatient Trial
Linagliptin Inpatient Trial: A Randomized Controlled Trial on the Safety and Efficacy of Linagliptin (Tradjenta®) Therapy for the Inpatient Management of General Surgery Patients With Type 2 Diabetes
Status: Enrolling
Updated:  12/31/1969
University of Colorado
1161
mi
from 43215
Denver, CO
Linagliptin Inpatient Trial
Linagliptin Inpatient Trial: A Randomized Controlled Trial on the Safety and Efficacy of Linagliptin (Tradjenta®) Therapy for the Inpatient Management of General Surgery Patients With Type 2 Diabetes
Status: Enrolling
Updated: 12/31/1969
University of Colorado
1161
mi
from 43215
Denver, CO
Click here to add this to my saved trials
Linagliptin Inpatient Trial
Linagliptin Inpatient Trial: A Randomized Controlled Trial on the Safety and Efficacy of Linagliptin (Tradjenta®) Therapy for the Inpatient Management of General Surgery Patients With Type 2 Diabetes
Status: Enrolling
Updated:  12/31/1969
Emory University Hospital
432
mi
from 43215
Atlanta, GA
Linagliptin Inpatient Trial
Linagliptin Inpatient Trial: A Randomized Controlled Trial on the Safety and Efficacy of Linagliptin (Tradjenta®) Therapy for the Inpatient Management of General Surgery Patients With Type 2 Diabetes
Status: Enrolling
Updated: 12/31/1969
Emory University Hospital
432
mi
from 43215
Atlanta, GA
Click here to add this to my saved trials
Linagliptin Inpatient Trial
Linagliptin Inpatient Trial: A Randomized Controlled Trial on the Safety and Efficacy of Linagliptin (Tradjenta®) Therapy for the Inpatient Management of General Surgery Patients With Type 2 Diabetes
Status: Enrolling
Updated:  12/31/1969
Grady Memorial Hospital
435
mi
from 43215
Atlanta, GA
Linagliptin Inpatient Trial
Linagliptin Inpatient Trial: A Randomized Controlled Trial on the Safety and Efficacy of Linagliptin (Tradjenta®) Therapy for the Inpatient Management of General Surgery Patients With Type 2 Diabetes
Status: Enrolling
Updated: 12/31/1969
Grady Memorial Hospital
435
mi
from 43215
Atlanta, GA
Click here to add this to my saved trials
Linagliptin Inpatient Trial
Linagliptin Inpatient Trial: A Randomized Controlled Trial on the Safety and Efficacy of Linagliptin (Tradjenta®) Therapy for the Inpatient Management of General Surgery Patients With Type 2 Diabetes
Status: Enrolling
Updated:  12/31/1969
Rush University Medical Center
277
mi
from 43215
Chicago, IL
Linagliptin Inpatient Trial
Linagliptin Inpatient Trial: A Randomized Controlled Trial on the Safety and Efficacy of Linagliptin (Tradjenta®) Therapy for the Inpatient Management of General Surgery Patients With Type 2 Diabetes
Status: Enrolling
Updated: 12/31/1969
Rush University Medical Center
277
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
Linagliptin Inpatient Trial
Linagliptin Inpatient Trial: A Randomized Controlled Trial on the Safety and Efficacy of Linagliptin (Tradjenta®) Therapy for the Inpatient Management of General Surgery Patients With Type 2 Diabetes
Status: Enrolling
Updated:  12/31/1969
Boston Med Ctr
642
mi
from 43215
Boston, MA
Linagliptin Inpatient Trial
Linagliptin Inpatient Trial: A Randomized Controlled Trial on the Safety and Efficacy of Linagliptin (Tradjenta®) Therapy for the Inpatient Management of General Surgery Patients With Type 2 Diabetes
Status: Enrolling
Updated: 12/31/1969
Boston Med Ctr
642
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Screening of Subjects With Type I Diabetes to Determine Eligibility for Islet Transplantation
Screening of Subjects With Type I Diabetes to Determine Eligibility for Islet Transplantation
Status: Enrolling
Updated:  12/31/1969
Diabetes Research Institute
992
mi
from 43215
Miami, FL
Screening of Subjects With Type I Diabetes to Determine Eligibility for Islet Transplantation
Screening of Subjects With Type I Diabetes to Determine Eligibility for Islet Transplantation
Status: Enrolling
Updated: 12/31/1969
Diabetes Research Institute
992
mi
from 43215
Miami, FL
Click here to add this to my saved trials
Equivalence of A Stable Liquid Glucagon Formulation With Freshly Reconstituted Lyophilized Glucagon
Equivalence of A Stable Liquid Glucagon Formulation With Freshly Reconstituted Lyophilized Glucagon
Status: Enrolling
Updated:  12/31/1969
Massachusetts General Hospital
643
mi
from 43215
Boston, MA
Equivalence of A Stable Liquid Glucagon Formulation With Freshly Reconstituted Lyophilized Glucagon
Equivalence of A Stable Liquid Glucagon Formulation With Freshly Reconstituted Lyophilized Glucagon
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Effect of Saxagliptin on EPCs as a Cellular Biomarker for Evaluating Endothelial Dysfunction in Early T2DM Patients
Effect of Saxagliptin (DPP-4 Inhibitor) on Endothelial Progenitor Cells (EPCs) as a Cellular Biomarker for Evaluating Endothelial Dysfunction in Early Type 2 Diabetes Patients
Status: Enrolling
Updated:  12/31/1969
Medical Faculty Associates
328
mi
from 43215
Washington,
Effect of Saxagliptin on EPCs as a Cellular Biomarker for Evaluating Endothelial Dysfunction in Early T2DM Patients
Effect of Saxagliptin (DPP-4 Inhibitor) on Endothelial Progenitor Cells (EPCs) as a Cellular Biomarker for Evaluating Endothelial Dysfunction in Early Type 2 Diabetes Patients
Status: Enrolling
Updated: 12/31/1969
Medical Faculty Associates
328
mi
from 43215
Washington,
Click here to add this to my saved trials
User Study for Enhanced Meter Feature
User Study for the Evaluation of an Enhanced Meter Feature Using an AgaMatrix BGMS
Status: Enrolling
Updated:  12/31/1969
Atlanta Diabetes Associates
432
mi
from 43215
Atlanta, GA
User Study for Enhanced Meter Feature
User Study for the Evaluation of an Enhanced Meter Feature Using an AgaMatrix BGMS
Status: Enrolling
Updated: 12/31/1969
Atlanta Diabetes Associates
432
mi
from 43215
Atlanta, GA
Click here to add this to my saved trials
Behavioral Activation Therapy for Both Depression and Diabetes Vs. Diabetes Alone Delivered Via Group Visits
Behavioral Activation Therapy for Both Depression and Diabetes Vs. Diabetes Alone Delivered Via Group Visits
Status: Enrolling
Updated:  12/31/1969
Providence VAMC
619
mi
from 43215
Providence, RI
Behavioral Activation Therapy for Both Depression and Diabetes Vs. Diabetes Alone Delivered Via Group Visits
Behavioral Activation Therapy for Both Depression and Diabetes Vs. Diabetes Alone Delivered Via Group Visits
Status: Enrolling
Updated: 12/31/1969
Providence VAMC
619
mi
from 43215
Providence, RI
Click here to add this to my saved trials
A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes
A Randomised, Double Blind, Cross-over Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes (SWITCH 2)
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
481
mi
from 43215
Birmingham, AL
A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes
A Randomised, Double Blind, Cross-over Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes (SWITCH 2)
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
481
mi
from 43215
Birmingham, AL
Click here to add this to my saved trials
A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes
A Randomised, Double Blind, Cross-over Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes (SWITCH 2)
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
470
mi
from 43215
Haleyville, AL
A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes
A Randomised, Double Blind, Cross-over Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes (SWITCH 2)
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
470
mi
from 43215
Haleyville, AL
Click here to add this to my saved trials
A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes
A Randomised, Double Blind, Cross-over Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes (SWITCH 2)
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
555
mi
from 43215
Montgomery, AL
A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes
A Randomised, Double Blind, Cross-over Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes (SWITCH 2)
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
555
mi
from 43215
Montgomery, AL
Click here to add this to my saved trials
A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes
A Randomised, Double Blind, Cross-over Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes (SWITCH 2)
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
443
mi
from 43215
Tuscumbia, AL
A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes
A Randomised, Double Blind, Cross-over Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes (SWITCH 2)
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
443
mi
from 43215
Tuscumbia, AL
Click here to add this to my saved trials
A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes
A Randomised, Double Blind, Cross-over Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes (SWITCH 2)
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
1655
mi
from 43215
Chandler, AZ
A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes
A Randomised, Double Blind, Cross-over Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes (SWITCH 2)
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
1655
mi
from 43215
Chandler, AZ
Click here to add this to my saved trials
A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes
A Randomised, Double Blind, Cross-over Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes (SWITCH 2)
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
1662
mi
from 43215
Phoenix, AZ
A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes
A Randomised, Double Blind, Cross-over Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes (SWITCH 2)
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
1662
mi
from 43215
Phoenix, AZ
Click here to add this to my saved trials
A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes
A Randomised, Double Blind, Cross-over Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes (SWITCH 2)
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
1638
mi
from 43215
Tucson, AZ
A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes
A Randomised, Double Blind, Cross-over Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes (SWITCH 2)
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
1638
mi
from 43215
Tucson, AZ
Click here to add this to my saved trials
A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes
A Randomised, Double Blind, Cross-over Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes (SWITCH 2)
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
623
mi
from 43215
Little Rock, AR
A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes
A Randomised, Double Blind, Cross-over Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes (SWITCH 2)
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
623
mi
from 43215
Little Rock, AR
Click here to add this to my saved trials
A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes
A Randomised, Double Blind, Cross-over Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes (SWITCH 2)
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
1965
mi
from 43215
Costa Mesa, CA
A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes
A Randomised, Double Blind, Cross-over Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes (SWITCH 2)
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
1965
mi
from 43215
Costa Mesa, CA
Click here to add this to my saved trials
A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes
A Randomised, Double Blind, Cross-over Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes (SWITCH 2)
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
1969
mi
from 43215
Downey, CA
A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes
A Randomised, Double Blind, Cross-over Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes (SWITCH 2)
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
1969
mi
from 43215
Downey, CA
Click here to add this to my saved trials
A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes
A Randomised, Double Blind, Cross-over Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes (SWITCH 2)
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
1939
mi
from 43215
El Cajon, CA
A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes
A Randomised, Double Blind, Cross-over Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes (SWITCH 2)
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
1939
mi
from 43215
El Cajon, CA
Click here to add this to my saved trials
A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes
A Randomised, Double Blind, Cross-over Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes (SWITCH 2)
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
1988
mi
from 43215
Fresno, CA
A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes
A Randomised, Double Blind, Cross-over Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes (SWITCH 2)
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
1988
mi
from 43215
Fresno, CA
Click here to add this to my saved trials
A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes
A Randomised, Double Blind, Cross-over Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes (SWITCH 2)
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
1969
mi
from 43215
Hawaiian Gardens, CA
A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes
A Randomised, Double Blind, Cross-over Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes (SWITCH 2)
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
1969
mi
from 43215
Hawaiian Gardens, CA
Click here to add this to my saved trials
A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes
A Randomised, Double Blind, Cross-over Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes (SWITCH 2)
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
1973
mi
from 43215
Huntington Park, CA
A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes
A Randomised, Double Blind, Cross-over Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes (SWITCH 2)
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
1973
mi
from 43215
Huntington Park, CA
Click here to add this to my saved trials
A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes
A Randomised, Double Blind, Cross-over Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes (SWITCH 2)
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
2027
mi
from 43215
Lincoln, CA
A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes
A Randomised, Double Blind, Cross-over Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes (SWITCH 2)
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
2027
mi
from 43215
Lincoln, CA
Click here to add this to my saved trials
A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes
A Randomised, Double Blind, Cross-over Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes (SWITCH 2)
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
1974
mi
from 43215
Long Beach, CA
A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes
A Randomised, Double Blind, Cross-over Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes (SWITCH 2)
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
1974
mi
from 43215
Long Beach, CA
Click here to add this to my saved trials
A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes
A Randomised, Double Blind, Cross-over Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes (SWITCH 2)
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
1942
mi
from 43215
Montclair, CA
A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes
A Randomised, Double Blind, Cross-over Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes (SWITCH 2)
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
1942
mi
from 43215
Montclair, CA
Click here to add this to my saved trials
A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes
A Randomised, Double Blind, Cross-over Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes (SWITCH 2)
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
1976
mi
from 43215
North Hollywood, CA
A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes
A Randomised, Double Blind, Cross-over Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes (SWITCH 2)
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
1976
mi
from 43215
North Hollywood, CA
Click here to add this to my saved trials